Property:Results during intervention
This is a property of type Text.
H
Hajimohammadebrahim-Ketabforoush et al. (2019): Effect of Vitamin D Supplementation on Postcraniotomy Pain After Brain Tumor Surgery: A Randomized Clinical Trial +
No significant differences in VAS scores;
No significant differences in doses of analgesic medication consumption +
Hajimohammadebrahim-Ketabforoush et al. (2019): Effect of Vitamin D Supplementation on Postcraniotomy Pain After Brain Tumor Surgery: A Randomized Clinical Trial +
Increase in 25(OH) D on the fifth postoperative day in intervention arm was statistically significant compared with the control arm (p = 0.001) +
Halyard et al. (2007): Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4) +
No significant differences in the interval to taste alterations;
the only factor that had a significant affect in influencing the outcome was the amount of oral mucosa in the radiation field (p = 0.004)
+ Zinc sulfate did not favorably affect most other clinical parameters either +
Halyard et al. (2007): Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4) +
Not significant taste alterations during the first 2 months between the arms (p = 0.16) +
Halyard et al. (2007): Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4) +
No statistically significant differences +
Halyard et al. (2007): Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4) +
As many as 99% of zinc-treated patients maintained their weight in contrast to 92% of placebo-exposed patients (p = 0.04) +
Heggie et al. (2002): A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue +
NA +
Heggie et al. (2002): A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue +
NA +
Heggie et al. (2002): A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue +
NA +
Heggie et al. (2002): A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue +
No significant difference between the arms at each assessed time point (p = 0.15-0.94); this was also the case with the duration of the reaction. +
Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer +
NA +
Hejazi et al. (2016): Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study +
NA +
Henning et al. (2015): Randomized Clinical Trial of Brewed Green and Black Tea in Men With Prostate Cancer Prior to Prostatectomy +
NI +
Henning et al. (2015): Randomized Clinical Trial of Brewed Green and Black Tea in Men With Prostate Cancer Prior to Prostatectomy +
NI +
Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy +
After 12 weeks:
No difference in the intervention arm (Baseline: M = 99.3 – 12 weeks: M = 91.9; MD = 7.4) compared to the placebo arm (Baseline - 12 weeks MD = 7.4); p = 0.92.
After 24 weeks:
Mean difference between the intervention arm and the placebo arm = 3.5 points; 95% CI: -6.5, -0.4; p = 0.03, representing a significant reduction in the intervention arm compared to the placebo arm. +
Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy +
No difference between arms (12 weeks: p=0.20; 24 weeks: p=0.51), higher values in both arms over time +
Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy +
No difference between arms +
Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy +
After 12 weeks:
Lower values for the intervention arm (higher CIPN) compared to the placebo arm (Baseline to 12 weeks: Intervention: -5.2 points vs. Placebo: -4.5 points), but the difference is not significant (linear regression, adjusted for baseline values: 0.9 points between arms, 95% CI: -2.2, 0.4; p = 0.17). There is a higher likelihood for the intervention arm to decrease by more than 5 points on the FACT-NTX, but this is not significant (OR: 1.48; 38% vs. 30%; p = 0.08)
After 24 weeks:
Baseline to 24 weeks: Intervention arm -5.3 points vs. placebo arm -3.6 points; linear regression: the intervention arm had 1.8 points less than the placebo arm, indicating a significant difference between arms (95% CI: -3.2, -0.4; p = 0.01), meaning more self-reported neuropathy symptoms in the intervention arm. There is a greater likelihood for the intervention arm to decrease by more than 5 points on the FACT-NTX (OR: 1.57; 38% vs. 28%; p = 0.05). +
Hershman et al. (2018): Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine +
Baseline to week 104 showed no differences between arms (p>0.05) +
Hershman et al. (2018): Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine +
Baseline to week 104 showed no differences between arms (p>0.05) +